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ABSTRACT
Background and Objectives:  Glycoprotein 96 is the primary chaperone of the endoplasmic reticulum. Immunization with 
it induced potent Cytotoxic T lymphocyte responses to intracellular bacteria. S. typhimurium is a facultative intracellular 
bacterium and acquired resistance against this bacterium mainly depends on activity of Cytotoxic T cells. This study 
aimed to evaluate the capacity of Glycoprotein 96 rich lysate as a vaccine candidate to induce a protective immune 
response in mice against a lethal dose challenge with Salmonella typhimurium.
Materials  and  Methods:  Mice  were  infected  with  S.  typhimurium.  Then  their  spleens  and  livers  were  harvested 
and homogenized and the protein content of whole crude lysate was enriched using ammonium sulfate precipitation. 
SDS-polyacrylamide gel electrophoresis transfer method was used for enrichment of the protein from crude sample. 
Immunoblotting was conducted to detect Glycoprotein 96. Isoelectric point was achieved through the use of isoelectric 
focusing. PBS and whole crude lysate (from uninfected and infected mice) were injected to mice of test group, mice of 
control-1 group and mice of control-2 group, respectively, on days 0 and 14. Twenty-one days after the last immunization, 
the LD50 and bacterial loads of livers and spleens were determined.
Results and Conclusion: Immunization with Glycoprotein 96 rich lysate isolated from livers and spleens of S. typhimurium-
infected mice induced protection against infection by S. typhimurium.  Also, the bacterial burden of livers and spleens in 
mice that received gp96 rich lysate significantly decreased when compared to that of mice in the control groups.
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INTRODUCTION
In  humans,  ingestion  of  various  Salmonella 
serovars gives rise to infection of the small intestine 
followed  by  gastroenteritis.  A  small  number  of 
Salmonella serotypes can lead to systemic infection 
and enteric fever. Typhoid fever, which is caused by 
Salmonella typhi, is the prototype of such disease in 
humans (1). 
In  contrast  to  the  severe  outcome  of  disease 
in  humans,  S.  typhi  is  avirulent  in  most  animals, 
including  mice.  However,  in  mice,  infection  with 
Salmonella  typhimurium  results  in  enteric  fever, 
with symptoms similar to those observed in humans 
after their infection with S. typhi (2). S. typhimurium 
infection in mice is, therefore, widely accepted as an 
experimental model for typhoid fever in humans (1, 3).
S.  typhimurium  is  a  facultative  intracellular 
bacterium with intracellular growth and replication 
essential for its virulence (4). The phase of early 
innate immunity is followed by activation of a complex 
host response that suppresses the growth of bacteria 
in tissues. Both T lymphocytes and macrophages are 173   MICe vACCINATION wITH GP96 RICH lySATe 
involved in cell-mediated immunity to Salmonella 
infection,  while  antibodies  also  play  a  role  (5). 
Although it has been shown in numerous prior studies 
that  CD4+ T  cells  are  of  greater  importance  than 
CD8+ T cells in immunity against S. typhimurium. 
There is also evidence for participation of CD8+ T 
cells in immunity to S. typhimurium (2).  Therefore, 
like many intracellular bacteria, acquired resistance 
against S. typhimurium depends on CD8+ T cells (2). 
This has created major hurdles to vaccinations using 
killed and antigen based vaccines (6).
Vaccination with heat shock protein (hsp)-peptide 
complexes could be one approach to overcome the 
current hurdles. The ability of heat shock proteins 
to:  (a)  chaperone  peptides,  including  antigenic 
peptides; (b) interact with antigen presenting cells 
through a receptor; (c) stimulate antigen presenting 
cells  to  secrete  inflammatory  cytokines;  and  (d) 
mediate  maturation  of  dendritic  cells,  permit  the 
utilization  of  these  proteins  to  develop  a  new 
generation of prophylactic and therapeutic vaccines 
against cancers and infectious diseases (7). 
Glycoprotein 96 (Gp96), also known as glucose-
regulated protein (grp94) is the primary chaperone 
of the endoplasmic reticulum (8). Immunization with 
Gp96 induced potent CTL responses to peptides of 
tumor antigens (9, 10), viral antigens (11-14), model 
antigens (15, 16), minor histocompatibility antigens 
(15) and intracellular bacteria (17). 
We  tested  the  capacity  of  Gp96  rich  lysate 
produced from liver and spleen cells of mice infected 
with S. typhimurium as a vaccine candidate to induce 
a  protective  immune  response  in  mice  against  a 
lethal dose challenge with S. typhimurium.
MATeRIAlS  AND  MeTHODS
 
Animal  experimentation.  Six  to  eight-week-
old  male  BALB/c  mice  were  obtained  from  the 
Razi  institute  (Karaj,  Iran). All  experiments  were 
in  accordance  with  the  Animal  Care  and  Use 
Protocol of Urmia University of Medical Sciences. 
S.  typhimurium  PTCC  (Persian  Type  Culture 
Collection)  1735  was  obtained  from  the  culture 
collection  of  The  Razi  Institute,  Karaj,  Iran.  For 
obtaining the Gp96 rich lysate from the spleen and 
liver of the infected mice, twenty mice were infected 
with  3×106  bacterial  cells  via  intraperitoneal 
injection (IP). The mean number of bacteria in all 
experiments was determined using the McFarland 
nephelometer standards (18).
Generation of Gp96 rich lysate. S. typhimurium 
is believed to replicate within macrophages during 
growth in the spleen and liver (4), so spleens and 
livers of the infected mice were harvested and mixed 
on day seven, washed twice, and homogenized with 
a lysis buffer (17). The lysis buffer consisted of 0.1M 
Tris/Hcl buffer at pH=7.8, containing 0.05% Triton 
X-100, 2mM EDTA and 5 µl of Protease inhibitor 
cocktail (Sigma). The volumes of the lysis buffer 
added  were  5mL/mg  for  liver  and  spleen.  After 
three  freeze-thaw  cycles,  the  whole  crude  lysate 
was centrifuged (14,000 × RPM at 4°C for 5 min). 
After centrifugation, supernatant was removed and 
a crude sample enriched of the protein was produced 
using ammonium sulfate precipitation (19).
SDS-PAGE  transfer  method  was  used  for 
enrichment  of  the  protein  from  crude  sample. 
Proteins were eluted from the gel by homogenizing 
as described elsewhere (20). 
Following separation by SDS-PAGE, the proteins 
were transferred onto a PVDF membrane using a 
semi-dry transfer method. Only fractions containing 
gp96 were used for experiments. Isoelectric points 
were achieved through the use of isoelectric focusing 
(21).
The protein content of samples was determined 
by the Bradford method (22). Sterility testing was 
performed  to  exclude  bacterial  contamination  of 
samples by culturing of the samples on TSA for 24 
hours at 37°C.
evaluation  of  the  immunogenicity  of  Gp96 
rich lysate. 144  mice  were  distributed  into  three 
major groups: Mice in the test group were injected 
subcutaneously  with  50µg  of  Gp-96  rich  lysate 
dissolved in PBS on days 0 and 14. Mice as control-1 
group and control-2 group immunized with PBS and 
whole crude lysate of liver and spleen cells (50µg) 
of  uninfected  mice  dissolved  in  PBS  (Since  we 
used the portion of lysate contained molecules with 
molecular weights near that of gp96 for vaccination, 
the lysate used as a vaccine candidate for mice of 
the test group was gp96 rich compared against the 
whole crude lysate used for mice of the control-2 
group  for  determining  whether  uninfected  whole 
cell lysate has any effects on producing immunity or 
not), respectively, using the same protocol. Each of 
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six subgroups.
For determining the 50% lethal doses(LD50), one 
week after the last immunization, 0.2-mL aliquots 
containing 108, 107, 106, 105, 104 or 103  cells of 
viable  pathogenic  S.typhimurium  were  prepared, 
and each dose of bacteria was inoculated into the 
8  mice  of  each  control  and  test  subgroup  via  IP 
injections (3). LD50 was determined 21 days after 
the challenge (23).
Determination of the bacterial loads in spleens 
and livers. According to the same protocol described 
above, 30 BALB/c mice divided in three groups were 
immunized subcutaneously with Gp96 isolated from 
livers and spleens of infected mice (test group), PBS 
(control-1 group) or crude lysate from uninfected 
mice (control-2 group). Twenty-one days after the 
last  immunization,  the  mice  were  infected  via  IP 
injections with 102 live S.typhimurium. Forty-eight 
hours later, mice were sacrificed, and the spleen and 
liver of each mouse was homogenized individually, 
with 10µl of appropriate dilutions [1/10 and 1/100 
with Triton X-100 (0.05%)] plated on trypticase soy 
Agar plates. One day after culturing at 37°C, the log 
of colony forming units (CFUs) were determined (24).
ReSUlTS
SDS-PAGe of the lysate of liver and spleen 
cells. The results of SDS-PAGE of the lysate of liver 
and spleen cells showed several protein bands with 
different molecular weights, however bands with the 
molecular weight between 66,200-116,000 were cut 
from the gel and enriched by gel transfer method 
(Fig. 1).
Detection of the gp96 band through the use 
of western blotting. The results of western blotting 
using an anti-gp96 antibody indicated the existence 
of gp96 in the lysate of liver and spleen cells (Fig. 2). 
Determination  of  Isoelectric  point  of 
Glycoprotein 96 rich lysate. The pI of Gp96 is 4.74. 
So, in isoelectric focusing of the gp96 rich lysate, a 
heavy band between pI 4.5 and 5.2 has been shown 
(Fig. 3).
Protection  of  mice  against  S.  typhimurium 
challenge. Seven days after the last immunization, 
survival rates of mice challenged with 103, 104, 105, 
106, 107 and 108 viable S. typhimurium inocula were 
analyzed (Table 1). When challenged with 105, 106, 
107 and 108 bacteria, the survival rates of mice in 
the test group were greater than those of mice in the 
control-1 and control-2 groups. The LD50 for the 
test group (2.9 × 107) was 1.71 × 103 and 1.38 × 103 
fold greater than those of the control-1 (1.69 × 104) 
and control-2 (2.1 × 104) groups, respectively. 
Bacterial  loads  in  the  liver  and  spleen.  To 
analyze  the  protective  effects  of  gp96  rich  lysate 
against  S.  typhimurium  infection,  the  log  of  the 
bacterial  CFUs  in  the  culture  of  0.1  dilutions  of 
homogenized  livers  and  spleens  was  determined. 
As shown in Fig. 4-A, cultures of 0.1 homogenized 
spleens of mice in the test group had significantly 
less  mean  bacterial  colony  counts  compared 
with those of mice in the control-1 and control-2 
groups  (p  <  0.001  and  p  <  0.001,  respectively). 
Additionally, the mean bacterial colony counts in 
cultures of 0.1 homogenized livers of mice in the 
challenge dosea Survival Rate (%)b
control-1 group control-2 group test group
103 7/8 (87.5%) 8/8 (100%) 8/8 (100%)
104 4/8 (50%) 4/8 (50%) 8/8 (100%)
105 3/8 (37.5%) 2/8 (25%) 7/8 (87.5%)
106 0/8 (%0) 1/8 (%12.5) 6/8 (75%) 
107 0/8 (%0) 0/8 (%0) 5/8 (62.5%) 
108 0/8 (%0) 0/8 (%0) 5/8 (62.5٪) 
Notes: aMice were challenged with the indicated dose of S. typhimurium (7 days after the second immunization).
bSurvival rate reported 21 days after the intraperitoneal challenge with viable S. typhimurium.
Table 1. The survival rate of mice immunized with PBS (control-1 group), whole crude lysate of liver and spleen cells of 
infected mice (control-2 group) or gp96 rich lysate (test group).175   MICe vACCINATION wITH GP96 RICH lySATe 





Fig.ure  2.- Gp96 expression of the lysate of liver and spleen cells. 
Western blotting using an anti-gp96 antibody indicated the existence of 
gp96 in the lysate of liver and spleen cells.1: negative control 2: gp96 rich 
lysate of spleen and liver 3: ColorBurst marker (Sigma) (210-8KDa). 
Formatted: Left-to-right
Fig.  1.  SDS-polyacrylamide  gel  electrophoresis  (SDS-
PAGE) of the lysate of liver and spleen cells.1: Protein bands 
from crude sample. 2: protein marker with molecular mass 
between 14400-116000 (Fermentas) .
Fig. 2. Gp96 expression of the lysate of liver and spleen cells.
Western blotting using an anti-gp96 antibody indicated the 
existence of gp96 in the lysate of liver and spleen cells.1: 
negative control 2: gp96 rich lysate of spleen and liver 3: 
ColorBurst marker (Sigma) (210-8KDa).
Fig. 3. Determination of Isoelectric point of Glycoprotein 96 
rich lysate by Isoelectric focusing. 1: Gp96 rich lysate from 
liver and spleen cells of mice infected with S. typhimurium. 
2: IEF markers 3-10 lyophillized protein test mixture for pI 
determination (Serva) were used. pI 4.2: Glucose Oxidase 
(A. niger), pI 4.5: Trypsin inhibitor(soybean), pI 5.2, 5.3: 
Beta- lactoglubolin.
Fig. 4. The bacterial loads in livers and spleens after 
challenging with S. typhimurium.
A- The log of CFUs in the culture of 10 × dilutions of spleens. 
B- The log of CFUs in the culture of 10 × dilutions of livers.   
The log CFUs indicated are the means ± SEM. *** p < 0.001
The  mean  bacterial  colony  counts  in  cultures  of  0.1 
homogenized livers and spleens of mice in the test group 
were significantly less than those of mice in the control-1 and 
control-2 groups (p < 0.001 and p < 0.001, respectively). 
Fig.ure 3 .:  Determination  of  Isoelectric  point  of  Glycoprotein 96  rich 
lysate by Isoelectric focusing. 1: Gp96 rich lysate from liver and spleen 
cells  of  mice  infected  with  S. typhimurium.  2:  IEF  markers  3-10 
lyophillized protein test mixture for pI determination (Serva) were used. 
pI 4.2: Glucose Oxidase (A.niger), pI 4.5: Trypsin inhibitor(soybean), pI 





Fig.ure 1.-: SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of
the lysate of liver and spleen cells.1: Protein bands from crude sample. 2: 









Fig.ure 4.- The bacterial loads in livers and spleens after challenging 
with S. typhimurium.
A- The log of CFUs in the culture of 10× dilutions of spleens. B- The log 
of CFUs in the culture of 10× dilutions of livers.   
The log CFUs indicated are the means ± SEM. *** p<0.001 
The mean bacterial colony counts in cultures of 0.1 homogenized livers 
and spleens of mice in the test group were significantly less than those of 
























Fig.ure 4.- The bacterial loads in livers and spleens after challenging 
with S. typhimurium.
A- The log of CFUs in the culture of 10× dilutions of spleens. B- The log 
of CFUs in the culture of 10× dilutions of livers.   
The log CFUs indicated are the means ± SEM. *** p<0.001 
The mean bacterial colony counts in cultures of 0.1 homogenized livers 
and spleens of mice in the test group were significantly less than those of 
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test group were significantly less than those of mice 
in the control-1 and control-2 groups (p < 0.001 and 
p < 0.001, respectively) (Fig. 4-B). Therefore, the 
results indicated that the bacterial burden of livers 
and spleens in mice that received gp96 rich lysate 
as a vaccine candidate significantly decreased when 
compared to that of mice in the control groups.
DISCUSSION
Heat shock proteins gp96, HSP70 and HSP90 are 
complexed to several cellular proteins and peptides 
because  of  their  chaperone  functions.  Effective 
vaccination using in vitro peptide loaded heat shock 
proteins (HSP), tumor-derived HSP and HSP fusion 
proteins has been shown in viral, parasite and tumor 
model systems (25). Vaccination with these HSP-
peptide  complexes  induces  immune  responses, 
especially  CD8+ antigen  specific  T  cell  responses 
against chaperoned peptide antigens. This allows for 
immunization with HSP-peptide complexes against 
tumor  antigens,  viruses  or  intracellular  bacteria 
(12).
Our results showed that an immunization with 
gp96 rich lysate of liver and spleen cells of mice 
infected  with  S.  typhimurium  effectively  induces 
protection  against  S.  typhimurium.  Zhang  et  al 
immunized the mice with gp96-peptide complexes 
extracted from different kinds of malignant tumors 
and the anti-tumor immunity induced by this vaccine 
candidate has been shown (5).
Navaratnam et al demonstrated the possibility of 
using gp96-peptide complexes isolated from cells 
expressing bovine herpes virus 1(BHV-1) proteins 
to induce Cytotoxic T-cells and antibody responses 
against BHV-1, so they showed the potential role 
of such preparations for vaccination against BHV-1 
(26). It has also been previously reported that gp96 
preparations isolated from organs of mice infected with 
intracellular bacteria induce cytotoxic T-lymphocyte 
responses and confer protection against intracellular 
bacteria (17). To our current knowledge, this is the 
first study illustrating the feasibility of vaccinating 
with gp96-peptide complexes against a facultative 
intracellular bacterial pathogen.
Zugel  et  al  also  showed  the  protective  effects 
of gp96-Peptide vaccination against infection with 
L  monocytogenes  and  M.  tuberculosis  in  a  mice 
model. They showed the feasibility of vaccinating 
with  gp96-peptide  complexes  against  intracellular 
bacteria (17), However our results confirmed these 
data about a facultative intracellular bacterium.
The  efficacy  of  gp96-peptide  complexes 
in  stimulation  of  immune  responses  against  S. 
typhimurium may be due to induction of cytotoxic T 
lymphocytes (CTLs) and T helper 1 (Th1) immune 
responses, by gp96-peptide complexes or gp96 by 
itself (17, 27). As mentioned above, CTLs play a 
critical  role  in  immunity  against  S.  typhimurium 
(2).  Also,  Th1  immune  responses  are  critical  in 
defending against S. typhimurium via activation of 
CTLs and macrophages (2, 28). In addition to cellular 
immunity, antibody response to Salmonella antigens 
participates  in  protection ( 2).  On  the  other  hand, 
Th1 immune responses promote shifting towards the 
production of antibodies, such as IgG2a, which can 
fight against S. typhimurium more efficiently (29).  
According to the results of our current study, the 
gp96 rich lysate of cells infected with S. typhimurium 
was an effective vaccine candidate against infection 
with  S.  typhimurium.  Given  that  S.  typhimurium 
infection  is  widely  accepted  as  an  experimental 
model for typhoid fever in humans (1), the gp96 
rich lysate of cells infected with S. typhi may be a 
good candidate to consider as a potential vaccine 
for typhoid in future studies. The absence of time 
and expenses needed for purification of molecules 
and avoidance of side effects pertaining to killed 
or  attenuated  vaccines ( 30)  are  among  several 
advantages of the vaccine candidate studied in this 
current research project.
To our knowledge, this study is the first of its 
kind to be carried out. Therefore, follow up studies 
are needed to confirm and extend these results.
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